EUVIMEDEUVIMED entdecken
Crossref

Research on the Metabolites and Antibacterial Activities of the Endophytic Fungus Talaromyces primulinus WZ‐883 From Pseudostellaria heterophylla

Bing-Yun Lu, Yuan-Xiang Gong, Yang Tao, Liang Feng, Jing Ni, Zhe Wang iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202502585 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Bing-Yun Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Jiangning Hospital of Chinese Medicine, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Talaromyces, Anti-Bacterial Agents. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research Project Funding from Affiliated Jiangning Hospital of Chinese Medicine, China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Investigation of the secondary metabolites from the endophytic fungus Talaromyces primulinus WZ‐883, derived from the leaf of fresh Pseudostellaria heterophylla , led to the isolation of one new meroterpenoid, talapenoid A ( 1 ), and one new isocoumarin, talaromarin A ( 5 ), along with eight known compounds chrodrimanin B ( 2 ), chrodrimanin E ( 3 ), carnemycin B ( 4 ), aspergillumarin A ( 6 ), aspergillumarin B ( 7 ), 4‐hydroxy‐2,2‐dimethyl‐3,4‐dihydrochromene‐6‐carboxylic acid ( 8 ), penicichrysogene B ( 9 ), and 1‐naphthalenecarboxylic acid ( 10 ). Their structures were primarily determined through extensive spectroscopic analyses. The configurations were assigned using ROESY spectra, ECD, and NMR calculations, as well as x‐ray single crystal diffraction. Among them, compound 1 is an uncommon meroterpenoid featuring a 5/6/6/6‐pentacyclic α‐pyrone skeleton. All isolated compounds were evaluated for their inhibitory effects on pathogenic bacteria. Compounds 1 – 4 and 9 exhibited selective antibacterial activity against methicillin‐resistant Staphylococcus aureus (MRSA), S. aureus , Enterococcus faecalis , and Escherichia coli , but showed no significant activity against Shigella sonnei and Klebsiella pneumoniae .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TalaromycesAnti-Bacterial AgentsMicrobial Sensitivity TestsMolecular StructureMolecular ConformationStructure-Activity RelationshipEscherichia coli

Stichwörter der Autor:innen

Pseudostellaria heterophyllaTalaromyces primulinusantibacterial activitiesisocoumarinsmeroterpenoids

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Affiliated Jiangning Hospital of Chinese Medicine, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.

ORCID-Profile: Zhe Wang

Förderung

  • National Natural Science Foundation of China
  • Research Project Funding from Affiliated Jiangning Hospital of Chinese Medicine, China Pharmaceutical University

Zitieren

APA

Lu, B. Y., Gong, Y. X., Tao, Y., Feng, L., Ni, J., & Wang, Z. (2025). Research on the Metabolites and Antibacterial Activities of the Endophytic Fungus Talaromyces primulinus WZ‐883 From Pseudostellaria heterophylla. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502585

Vancouver

Lu BY, Gong YX, Tao Y, Feng L, Ni J, Wang Z. Research on the Metabolites and Antibacterial Activities of the Endophytic Fungus Talaromyces primulinus WZ‐883 From Pseudostellaria heterophylla. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202502585

BibTeX
@article{Lu2025,
  author = {Lu, Bing-Yun and Gong, Yuan-Xiang and Tao, Yang and Feng, Liang and Ni, Jing and Wang, Zhe},
  title = {Research on the Metabolites and Antibacterial Activities of the Endophytic Fungus Talaromyces primulinus WZ‐883 From Pseudostellaria heterophylla},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202502585}
}
Kostenlos starten →